35th National Conference of the Italian Group for the Study of Neuromorphology, November 28-29, 2025
Vol. 69 No. s3 (2025): Proceedings of the 35th National Conference of the Italian Group for the Study of Neuromorphology

HIGH RESOLUTION MAGNETIC RESONANCE IMAGING TO ASSESS AXONAL DAMAGE IN NEUROPATHY MODELS

Bontempi P1, Mastropietro A2, Rizzo G2, Taccogna M2, Napolitano A3, Gerevini S4, Kraus MF5,6, Di Girolamo S5,7, Cavaletti G5,7, Tamburin S8 and Alberti P5,7 | 1Department of Engineering for Innovation Medicine, University of Verona, Verona, Italy; 2Institute for Biomedical Technologies, National Research Council (ITB-CNR), Segrate, Italy; 3Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy; 4Department of Neuroradiology, ASST Papa Giovanni XXIII, Bergamo, Italy; 5Experimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy 6S.C. Neuroscienze, Istituto Zooprofilattico Sperimentale del Piemonte Liguria e Valle D’Aosta, Torino, Italy; 7NeuroMI (Milan Center for Neuroscience), Milan, Italy; 8Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 12 December 2025
166
Views
0
Downloads

Authors

Peripheral neuropathies are common conditions whose treatment, in most cases, is still lacking due to an incomplete pathogenetic knowledge; therefore, preclinical in vivo models are crucial, but highly translational outcome measures are still needed in this field. High resolution diffusion MRI could be a surrogate, translational, biomarker to characterise early morphological changes as neuropathy ensues, creating a virtuous link between bench and bedside. We tested this approach in a proof-of-concept and a feasibility setting. We aimed at characterising MRI changes in a robust model of axonopathy that ensues after repetitive administration of paclitaxel (PTX). We compared 2 groups (n=12 each) of female Wistar rats: control (CTRL, vehicle treated, iv) and PTX (10mg/kg, 1qwx4, iv). At the end of treatment, neuropathy development was verified via Dynamic test, nerve conduction studies (NCS) and light microscopy of the caudal nerve. 7T MRI was performed on whole rat tails (collected after sacrifice and formalin-fixed, n=3/group) to study caudal nerves and the anatomical relationship with surrounding structures. High resolution anatomical images were acquired by means of a T1w sequence with a voxel size of 50x50x50 μm3. Diffusion weighted images were acquired in five b-shells: b of 500, 2000, 4500, 6000, 8000 sec*mm-2 with 15, 24, 33, 42, 51 isotropically distributed gradient directions and a voxel size of 125x125x125 μm3. Diffusion data were fitted with the Diffusion Tensor Imaging (DTI) classical model and Fractional Anisotropy (FA), Axial, Radial and Mean Diffusitìvity (AD, RD and MD) were computed. All selected outcome measures (dynamic test, NCS and morphological assessment of caudal nerves) demonstrated that nerve damage induction was satisfactory and consistent with a moderate-severe axonal polyneuropathy, making our cohort ideal to test 7T MRI implementation. Neuroimaging showed a decrease of FA (by 5%) and an increase of diffusivity, being the more relevant variation in RD (by 15%), in the PTX group if compared to control. These preliminary results may sustain the hypothesis of axonal damage leading to an increased water diffusivity in the PTX tissue microstructure. In summary, we provided preliminary promising data of the 7T MRI exploitation to study axonal damage in the preclinical setting.

Downloads

Download data is not yet available.

Citations

No refs.

How to Cite



1.
HIGH RESOLUTION MAGNETIC RESONANCE IMAGING TO ASSESS AXONAL DAMAGE IN NEUROPATHY MODELS: Bontempi P1, Mastropietro A2, Rizzo G2, Taccogna M2, Napolitano A3, Gerevini S4, Kraus MF5,6, Di Girolamo S5,7, Cavaletti G5,7, Tamburin S8 and Alberti P5,7 | 1Department of Engineering for Innovation Medicine, University of Verona, Verona, Italy; 2Institute for Biomedical Technologies, National Research Council (ITB-CNR), Segrate, Italy; 3Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy; 4Department of Neuroradiology, ASST Papa Giovanni XXIII, Bergamo, Italy; 5Experimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy 6S.C. Neuroscienze, Istituto Zooprofilattico Sperimentale del Piemonte Liguria e Valle D’Aosta, Torino, Italy; 7NeuroMI (Milan Center for Neuroscience), Milan, Italy; 8Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy. Eur J Histochem [Internet]. 2025 Dec. 12 [cited 2026 Jan. 19];69(s3). Available from: https://www.ejh.it/ejh/article/view/4480